Get the latest tech news
GLP-1 drugs linked to lower death rates in colon cancer patients
In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those taking glucagon-like peptide-1 (GLP-1) medications were less than half as likely to die within five years compared to those who weren’t on the drugs (15.5% vs. 37.1%
None
Or read this on Hacker News.jpg)
